Anti-cancer compounds targeting Ral GTPases and methods of using the same
US11472812B2 · kind B2 · utility
0Cited by
7References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2020 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Apr 30, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of inhibiting the growth or metastasis of a cancer in a subject by inhibiting a Ral GTPase in the subject, and small molecule inhibitors of Ral GTPases useful in the methods of the invention. Pharmaceutical compositions containing the compounds of the invention, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.